Clinical Trial Update: Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

View source ↗

Summary

A clinical trial update reports the effectiveness of cladribine tablets in participants with highly-active relapsing multiple sclerosis (CAMELOT-MS); the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Relapsing-Remitting Multiple Sclerosis | Status: COMPLETED | Results posted: 2024-12-18